Japan to become the next ‘hub’ for generic drugs market says new report

Feb. 15, 2012 - PRLog -- According to the report “Japan Generics Market Analysis”
Japan is expected to be the next generic hub, and cancer related generics exhibit vast potential.

The patent expiry of branded drugs and active ingredients will also act as a strong growth driver for the market in future. According to the findings of the report, the generics market in Japan stood at around US$ 9 Billion in 2010. It estimates that the growth in generic drugs will outshine the expansion in overall pharmaceutical market.

The government in Japan has taken several initiatives to ensure growth and promotion of generics industry in the country. Recently, special premium-based incentives have been given to pharmacists on generic promotion. In near future, the government plans to bring in more reforms in medical care system. This research talks about such revisions and reforms briefly to present a balanced outlook of the industry to clients. Analysis of current trends, profiles of key players in the Japanese generic market, and recent developments in the industry have also been included in the comprehensive study.

View the report here: http://www.pharmaceutical-market-research.com/publication...

View more generic drug market reports at
http://www.pharmaceutical-market-research.com/publication...
Pharmaceutical-Market-Research.com, the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.